NS310 Unit 5 B12 Marker Review Example

The Metabolite Over the Vitamin: A Unit 5 Biochemical Marker Review of a Borderline B12 in a 71-Year-Old Woman

[Student Name]

Purdue University Global

NS310: Nutritional Assessment

Unit 5 Biochemical Marker Review

[Instructor Name]

[Date]

The woman, her laboratory panel and its reference ranges are composite; the clinical reviews and biomarker report cited are real.

The Panel

The woman's primary care practice drew a routine panel after she mentioned feeling more tired than usual over the winter. She reports no numbness, tingling or memory change, takes a daily statin and a calcium supplement, and does not take metformin or an acid-reducing drug. The results, with the laboratory's reference ranges, were:

1. Serum vitamin B12: 238 pg/mL (reference 200 to 900).

2. Methylmalonic acid: 0.52 µmol/L (reference 0.00 to 0.40).

3. Total homocysteine: 16.8 µmol/L (reference 5 to 15).

4. Serum folate: 12.4 ng/mL (reference above 4.0).

5. Mean corpuscular volume: 96 fL (reference 80 to 100).

6. Estimated glomerular filtration rate: 72 mL/min/1.73 m2 (reference above 60).

On a quick read, four values are normal and two are mildly high. The review argues that the two mildly high values matter most.

Serum B12: Low in the Normal Range

Serum B12 is the usual first test and the weakest one. Most circulating B12 is bound to haptocorrin, a carrier that most cells cannot use; only the fraction bound to transcobalamin, called holotranscobalamin, is delivered to tissues (Green, 2017). A total serum value can therefore look adequate while cells are short. Values in the low-normal zone, roughly 200 to 350 pg/mL, are common in older adults and do not settle the question either way (Stabler, 2013). Her 238 pg/mL sits in that zone. It raises the question; it cannot answer it.

Methylmalonic Acid: The Functional Marker

Methylmalonic acid rises when cells lack B12, because a B12-dependent enzyme, methylmalonyl-CoA mutase, cannot convert methylmalonyl-CoA onward. That makes it a functional marker: it reports what the vitamin is or is not doing inside cells. In the clinical studies reviewed, methylmalonic acid was raised in nearly all patients with clinical B12 deficiency, which makes it the more sensitive of the available markers (Stabler, 2013).

It has one major confounder. Reduced kidney function raises methylmalonic acid independently of B12, because the kidneys clear it (Allen et al., 2018). Her eGFR of 72 is mildly reduced for her age but above 60, a level at which kidney function is unlikely to explain a value of 0.52. That is why the eGFR belongs in a B12 review even though it is not a nutrition marker.

Read alone, the serum B12 looks acceptable; read with a raised methylmalonic acid and a kidney function that cannot explain it, the panel suggests that her cells are not getting enough B12 even though her blood carries what looks like a normal amount.

Homocysteine: Supporting, Not Specific

Homocysteine rises when either B12 or folate is short, because both are needed to convert it to methionine. It also rises with low vitamin B6, reduced kidney function, hypothyroidism and some medicines, and with age itself (Green, 2017). Her value of 16.8 µmol/L is consistent with low B12, but it would be consistent with several other explanations too. It supports the methylmalonic acid finding; it could not carry the conclusion on its own.

Folate: Ruling Out the Rival

Folate deficiency would raise homocysteine without raising methylmalonic acid. Her folate of 12.4 ng/mL is well within range, which removes the main rival explanation for her homocysteine. Normal folate also matters for a practical reason: high folate intake can correct the anemia of B12 deficiency while the nerve damage continues, so knowing folate status helps a clinician read every other value (Allen et al., 2018).

MCV: A Normal Value That Does Not Reassure

B12 deficiency can cause large red cells, raising MCV. Hers is 96 fL, at the upper end of normal. A normal MCV does not exclude B12 deficiency, because macrocytosis appears late and can be masked by coexisting iron deficiency or thalassemia trait (Stabler, 2013). Its main value here is to show that there is no anemia yet, which suggests an early stage, if deficiency is present at all.

Units, Assays and the Laboratory's Ranges

Two practical points affect how the panel is read. The first is units. Many studies report serum B12 in picomoles per liter rather than picograms per milliliter; multiplying by 0.738 converts one to the other, so her 238 pg/mL is about 176 pmol/L. A writer comparing her value with a published cutoff must check which unit the paper used, or the comparison will be wrong by about a quarter.

The second is the assay. Reference ranges are set by each laboratory for its own method, and B12 immunoassays can disagree with one another, particularly near the low end of the range. The review therefore uses the laboratory's printed ranges for each value and treats published cutoffs as guides rather than rules. The same caution applies to methylmalonic acid, whose upper limit varies between laboratories. A value of 0.52 µmol/L is raised at this laboratory, and the review does not claim more than that.

Weighing the Markers Together

The values sort into three groups.

1. Consistent with low B12: borderline serum B12, raised methylmalonic acid, raised homocysteine, high-normal MCV.

2. Consistent with low folate: raised homocysteine only, contradicted by normal folate.

3. Consistent with kidney effects: raised methylmalonic acid and homocysteine, but an eGFR above 60 makes this an unlikely sole explanation.

Only the first explanation accounts for every value. The level of confidence is moderate, not high. Methylmalonic acid is mildly rather than strongly raised, there is a single measurement, and she has no neurological signs.

What Would Strengthen or Weaken the Conclusion

Three further pieces of evidence would change confidence.

1. A repeat methylmalonic acid, or a holotranscobalamin level, would confirm whether the functional shortage is persistent.

2. Intrinsic factor antibodies would test for pernicious anemia, which would change treatment from diet to injections or high oral doses.

3. A diet history would show her usual B12 intake from meat, fish, dairy, eggs and fortified foods, and whether she has reduced any of them recently.

A rising methylmalonic acid on repeat, or positive antibodies, would raise confidence. A normal repeat value would suggest the first result was a fluctuation or a laboratory variation.

Scope

A nutrition student can interpret these markers and recommend further assessment, but the decision to test for pernicious anemia or to treat belongs to her physician. The review would go to the practice with the three suggestions above, framed as questions for the clinician.

Why This Matters for an Older Adult

B12 deficiency in older adults is often subclinical and is commonly attributed to reduced absorption from food rather than to low intake (Allen et al., 2018). Its neurological effects can become permanent if missed. A panel that reports a normal-looking serum B12 can therefore give false reassurance, and the review's purpose is to show why the functional marker deserves the most weight.

References

Allen, L. H., Miller, J. W., de Groot, L., Rosenberg, I. H., Smith, A. D., Refsum, H., & Raiten, D. J. (2018). Biomarkers of Nutrition for Development (BOND): Vitamin B-12 review. The Journal of Nutrition, 148(Suppl. 4), 1995S-2027S. https://doi.org/10.1093/jn/nxy201

Green, R. (2017). Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood, 129(19), 2603-2611. https://doi.org/10.1182/blood-2016-10-569186

Stabler, S. P. (2013). Vitamin B12 deficiency. New England Journal of Medicine, 368(2), 149-160. https://doi.org/10.1056/NEJMcp1113996